Blog

December 14, 2016April 24, 2018

Ontario Colleges Seek Injunction Against Essilor Canada

The College of Optometrists of Ontario and the College of Opticians of Ontario are seeking an injunction to prevent Essilor of Canada/Clearly from dispensing prescription eyeglasses and contact lenses online to the Ontario public.

The Colleges issued a joint press release on December 14 stating, “It is illegal for anyone other than an optician, optometrist or physician to dispense prescription eyewear to an Ontario patient except under appropriate supervision or delegation. As regulatory bodies the Colleges have a responsibility to serve and to protect the public interest. This responsibility includes ensuring that Ontarians are only dispensed their corrective eyewear by an authorized, regulated health professional, which is based on a valid prescription.”

Dr. Paula Garshowitz, Registrar of the College of Optometrists of Ontario, explains, “This action isn’t about stopping online dispensing. This is about ensuring that Ontarians have full protection under Ontario laws.”

Infoclip.ca has reached out to Essilor of Canada for comment.

Read the complete statement from the Colleges here.

December 13, 2016May 20, 2026

Marc Jacobs Plays with Shapes

Unexpected. Unconventional. Unique. The Marc Jacobs Fall/Winter 2016 eyewear collection juxtaposes the avant-garde with conventional eyewear traditions.

Transparency and lightness are key on these geometrical shaped metal sunglasses (marc 101/s). The cat-eye shaped marc 100/s (photo) possesses a multi-layer lens construction in which the lenses relinquish their traditional functionality to become part of the frame design. Gold metal detailing on the frame front and acetate temple tips provide a luxurious effect to these innovative designs.

Distributed by Safilo: www.safilo.com

December 12, 2016April 24, 2018

Safilo and Christian Dior Couture Renew Licensing Agreement

Padua/Paris – SAFILO Group and Christian Dior Couture announce the renewal of their licensing agreement for the design, manufacturing and worldwide distribution of the Dior and Dior Homme collections of sunglasses and optical frames. The renewal period extends until December 31, 2020.

“DIOR eyewear has established itself as the leading trendsetter in sunglasses, says Luisa Delgado, CEO of SAFILO. This is the result of a remarkable combination of sophisticated capabilities, merging visionary
product design, industry-leading technical expertise and innovation, along with authentic manufacturing craftsmanship and consistent qualitative worldwide distribution.”

“DIOR is glad to continue its relationship with SAFILO, developing and marketing DIOR eyewear products that reflect the values of our brand.” comments Sidney Toledano, President and CEO of Christian Dior Couture.

Click HERE for the full press release.

December 12, 2016April 24, 2018

Safilo Communicates Closure of Licensing Agreement for Céline Eyewear

Padua – Safilo Group communicates that the licensing agreement for the design, manufacturing and worldwide distribution of the Céline collections of sunglasses and optical frames, will run to closure on December 31, 2017. Céline Eyewear joined the Safilo brand portfolio in 2012, and represents today just above 3% of Safilo’s worldwide sales concentrated mainly in Europe and North America.

For the full press release, click HERE.

December 9, 2016April 24, 2018

The Cooper Companies Announces Fourth Quarter and Full Year 2016 Results

The Cooper Companies announced financial results for the fiscal fourth quarter and full year ended October 31, 2016. Fourth quarter revenue increased 14% year-over-year to $518.7 million. Fiscal 2016 revenue increased 9% to $1,966.8 million.

Fourth quarter GAAP earnings per share (EPS) $1.23, up 48 cents or 64% from last year’s fourth quarter. Fiscal 2016 GAAP EPS $5.59, up 35% from fiscal 2015. Fourth quarter non-GAAP EPS $2.28, up 28 cents or 14% from last year’s fourth quarter. Fiscal 2016 non-GAAP EPS $8.44, up 13% from fiscal 2015.

Revenue $1,966.8 million, up 9.4% from fiscal 2015, up 7.3% pro forma.

Cash provided by operations $509.6 million and capital expenditures $152.6 million resulted in free cash flow of $357.0 million.

Commenting on the results, Robert S. Weiss, Cooper’s president and chief executive officer said, “I am pleased to report record revenue and free cash flow for the year. We accomplished this through market share gains, a successful push into the 1-Day silicone hydrogel space, growth in our Biofinity® franchise and very strong year in our CooperSurgical business. We enter fiscal 2017 with momentum and are well positioned for sustained growth in each of our businesses going forward.”

Click HERE for the full press release.